Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Balafa

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Medicine|November 8, 2021
The Association of Circulating CD14++CD16+ Monocytes, Natural Killer Cells and Regulatory T Cells Subpopulations With Phenotypes of Cardiovascular Disease in a Cohort of Peritoneal Dialysis PatientsAnila Duni, Georgios Vartholomatos, Olga Balafa, et al.
International Urology and Nephrology|October 24, 2022
Lower serum magnesium is a predictor of left ventricular hypertrophy in patients on dialysisOlga Balafa, Evangelia Dounousi, Ioannis Giannikouris, et al.
Journal of Hypertension|March 24, 2026
Feasibility of the extended, 48-h ambulatory blood pressure monitoring in hemodialysis patients: a multicenter studyC Torino, Francesca Mallamaci, Pantelis Sarafidis, et al.
Journal of Hypertension|June 23, 2026
Erratum: Feasibility of the extended, 48-h ambulatory blood pressure monitoring in hemodialysis patients: a multicenter studyC Torino, Francesca Mallamaci, Pantelis Sarafidis, et al.
Journal of Clinical Medicine|July 27, 2024
Cardiovascular and All-Cause Mortality Is Affected by Serum Magnesium and Diet Pattern in a Cohort of Dialysis PatientsIoannis Petrakis, Dimitra Bacharaki, Periklis Kyriazis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2023
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERAPatrick B Mark, Pantelis Sarafidis, Robert Ekart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 4, 2021
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney diseaseAlberto Ortiz, Charles J Ferro, Olga Balafa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 15, 2018
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTAPantelis A Sarafidis, Francesca Mallamaci, Charalampos Loutradis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 17, 2018
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTAPantelis A Sarafidis, Francesca Mallamaci, Charalampos Loutradis, et al.
Journal of Hypertension|July 11, 2020
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based studyFrancesca Mallamaci, Claudia Torino, Pantelis Sarafidis, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Medicine|November 8, 2021
The Association of Circulating CD14++CD16+ Monocytes, Natural Killer Cells and Regulatory T Cells Subpopulations With Phenotypes of Cardiovascular Disease in a Cohort of Peritoneal Dialysis PatientsAnila Duni, Georgios Vartholomatos, Olga Balafa, et al.
International Urology and Nephrology|October 24, 2022
Lower serum magnesium is a predictor of left ventricular hypertrophy in patients on dialysisOlga Balafa, Evangelia Dounousi, Ioannis Giannikouris, et al.
Journal of Hypertension|March 24, 2026
Feasibility of the extended, 48-h ambulatory blood pressure monitoring in hemodialysis patients: a multicenter studyC Torino, Francesca Mallamaci, Pantelis Sarafidis, et al.
Journal of Hypertension|June 23, 2026
Erratum: Feasibility of the extended, 48-h ambulatory blood pressure monitoring in hemodialysis patients: a multicenter studyC Torino, Francesca Mallamaci, Pantelis Sarafidis, et al.
Journal of Clinical Medicine|July 27, 2024
Cardiovascular and All-Cause Mortality Is Affected by Serum Magnesium and Diet Pattern in a Cohort of Dialysis PatientsIoannis Petrakis, Dimitra Bacharaki, Periklis Kyriazis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2023
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERAPatrick B Mark, Pantelis Sarafidis, Robert Ekart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 4, 2021
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney diseaseAlberto Ortiz, Charles J Ferro, Olga Balafa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 15, 2018
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTAPantelis A Sarafidis, Francesca Mallamaci, Charalampos Loutradis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 17, 2018
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTAPantelis A Sarafidis, Francesca Mallamaci, Charalampos Loutradis, et al.
Journal of Hypertension|July 11, 2020
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based studyFrancesca Mallamaci, Claudia Torino, Pantelis Sarafidis, et al.
Pageof 5